FDA Authorizes 6 on! PLUS Nicotine Pouches made by Altria

The FDA has granted marketing authorization to six on! PLUS nicotine pouch products manufactured by Helix Innovations LLC (an Altria joint venture). These include mint, tobacco, and wintergreen flavors in 6 mg and 9 mg strengths. This approval, the first under a new pilot program for fast-tracking reviews, confirms these products are appropriate for public health due to lower levels of harmful chemicals compared to other smokeless tobacco.

Key Takeaways:

Authorized Flavors: Mint, Tobacco, and Wintergreen.
Nicotine Strengths: Available in 6 mg and 9 mg options.
Health Evidence: Lower cancer risk and harmful chemicals than traditional smokeless products.
Pilot Program: First authorization under the FDA’s new fast-track review process.

FDA marketing authorization refers to the regulatory approval process that allows specific tobacco or nicotine products to be legally sold in the U.S. after demonstrating they are appropriate for the protection of public health. On Friday, the FDA authorized six new on! PLUS nicotine pouch products, marking a significant step for Altria in the rapidly growing oral nicotine market.

FDA Authorization Details: Flavors and Strengths

The authorization applies specifically to six variations of on! PLUS pouches. These products were reviewed under a pilot program launched in September to expedite the evaluation of such alternatives.

Product Brand	Authorized Flavors	Nicotine Strengths
on! PLUS	Mint, Tobacco, Wintergreen	6 mg, 9 mg

The FDA based its decision on evidence showing these products contain significantly lower levels of harmful constituents compared to other smokeless tobacco products, thereby posing a reduced risk of cancer and other serious health conditions.

Market Impact and Availability

Nicotine pouches are currently the fastest-growing tobacco product category in the U.S., valued for being a tobacco-leaf-free, inhalation-free alternative. This authorization follows the earlier approval of 20 Zyn products (owned by Philip Morris) in January.

Altria has confirmed that “on! PLUS will resume taking new orders for retail accounts in Florida, North Carolina, and Texas and on e-commerce soon.” This move underscores the industry’s heavy investment in smoke-free alternatives as consumer demand shifts away from traditional cigarettes.

Reference: Nicotine Pouch Products Authorized by the FDA

Author
Recent Posts

Matthew Ma

Marketing at Ecigator

With over a decade of experience in the e-cigarette industry, Matthew Ma is a seasoned expert in both the manufacturing and usage aspects of vaping products. His extensive background has provided him with a deep understanding of the intricacies and evolving dynamics of e-cigarettes.